ICM
JSPRW

Ionic Capital Management’s Japer Therapeutics Warrants JSPRW Stock Holding History

Ionic Capital Management’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-417,132
Closed -$20.9K – 221
2023
Q3 		$20.9K Sell
417,132
-26,079
-6% -$2.24K 0.01% 190
2023
Q2 		$62.2K Buy
443,211
+185,268
+72% +$28.5K 0.02% 164
2023
Q1 		$51.6K Sell
257,943
-201,448
-44% -$29.4K 0.02% 215
2022
Q4 		$13.8K Hold
459,391
– – ﹤0.01% 305
2022
Q3 		$36K Buy
459,391
+93,746
+26% +$8.18K ﹤0.01% 369
2022
Q2 		$33K Hold
365,645
– – ﹤0.01% 380
2022
Q1 		$121K Buy
365,645
+26,969
+8% +$15K 0.01% 345
2021
Q4 		$498K Buy
+338,676
New +$472K 0.06% 220

Other funds holding JSPRW

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
ZA
Zazove Associates Incline Village, Nevada $1.22B AUM 1.92% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Ionic Capital Management's JSPRW Position: Q4 2023 in Review

Ionic Capital Management sold out of Japer Therapeutics Warrants (JSPRW) in Q4 2023, closing a stake of 417,132 shares — an estimated $20.9K sold.

Ionic Capital Management first reported a position in JSPRW in Q4 2021 and held it in 8 quarters. The position peaked at $498K in Q4 2021. 6 funds tracked by Wall St. Rank hold JSPRW as of Q4 2023.

  • Ionic Capital Management reported no remaining Japer Therapeutics Warrants position as of Q4 2023 after selling out during the quarter.
  • Ionic Capital Management sold 417,132 Japer Therapeutics Warrants shares in Q4 2023, an estimated $20.9K.
  • Ionic Capital Management first reported a position in Japer Therapeutics Warrants in Q4 2021 and held it in 8 quarters.
  • Ionic Capital Management's Japer Therapeutics Warrants position peaked at $498K in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q4 2023.

Based on Ionic Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.